FABP4 and metabolic dysfunction-associated steatotic liver disease: For example, fatty acid binding protein 4 (FABP4), produced by LSEC in response to hyperglycaemia, VEGF and hypoxia, is increased in NAFLD and HCC patients (Milner et al., 2009; Laouirem et al., 2019).